Literature DB >> 34380347

A new flavonoid glycoside from Tapinanthus sp. (Loranthaceae) and evaluation of anticancer activity of extract and some isolated compounds.

Isaac Silvère Gade1,2,3, Corinne Chadeneau2, Tagne Simo Richard4, Alex De Théodore Atchade1, Emmanuel Talla3, Paul Seite2, Brigitte Vannier2, Jérôme Guillard5, Sophie Laurent6, Celine Henoumont6, Armel H Kamdje Nwabo4, Jean-Marc Muller2.   

Abstract

The present work describes the isolation and anticancer activity of Tapinanthus sp. which is a hemi parasitic plant harvested on Combretum glutinosum, the host plant. Phytochemical study afforded a new flavonoid glycoside, tapinantoside (1) isolated for the first time from natural source, alongside six known compounds (2-7). Structure of compounds were elucidated by extensive spectroscopic analyses including 1 D and 2 D NMR, mass spectrometry and by comparison with literature data. The anticancer activity of extract and some isolated compounds were evaluated on glioblastoma (U87MG, C6) and prostate (PC-3) cancer cells. The methanol leaves extract showed good anticancer activity against U87 (IC50 = 21.40 µg/mL) and PC-3 cells (IC50 = 10.26 µg/mL). Compound 3 powerfully inhibits the proliferation of C6 (IC50 = 38.84 µM) and PC-3 cells (IC50 = 21.33 µM), while its effect was moderated on U87MG cells. Compound 1 and 7 were not active on all tested cancer cell lines.

Entities:  

Keywords:  Tapinanthus sp.; anticancer activity; flavonoid glycoside; tapinantoside

Mesh:

Substances:

Year:  2021        PMID: 34380347     DOI: 10.1080/14786419.2021.1963243

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.488


  1 in total

1.  Actinoflavosides B-D, Flavonoid Type Glycosides from Tidal Mudflat-Derived Actinomyces.

Authors:  Hyeongju Jeong; Se Jin Jo; Munhyung Bae; Young Ran Kim; Kyuho Moon
Journal:  Mar Drugs       Date:  2022-09-05       Impact factor: 6.085

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.